$0.166400
0.00633.94%
At Close: -
$0.170500
0.00412.46%
After Hours: Sep 13, 7:28 PM EDT
15 minutes delayed
Kintara Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Kintara Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2023 | 2023-11-13 | $-1.83 | $-0.58 | -215.5 % |
Jun 2023 | 2023-09-18 | $-1.95 | $-1.05 | -85.7 % |
Mar 2023 | 2023-05-11 | $-1.94 | $-0.19 | -921.0 % |
Dec 2022 | 2023-02-14 | $-2.10 | $-3.16 | 33.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2022 | 2022-11-09 | $0 | $4.71M | -100.0 % |
Kintara Therapeutics (KTRA) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on May 14, 2024 for Q3.
The Actual EPS was $-0.05, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.